Eurofarma Innovation and Growth Strategy
16
1
NEURON
-VENTURES-
R$45mm
AuM
Founded in
2019
Worldwide investments,
focused in early-stage startups
with potential synergies with
Eurofarma's businesses
companies
In the portfolio
Target sectors include
•
•
Industries & Logistics,
Healthcare and
•
Diagnostics healthcare
boll
Hundreds of
chromatography
and 12 synthesis
chapels
6 laboratories
state-of-the-art
Invested
Portfolio
T the men's
OCEAN
DROP
rockcontent
PSICOLOGIAVIVA
Jusor You
Oli Nexfar
by PSYALIVE
Staggering
factory (minifactory
will be
able to produce
batches for
clinical studies)
eurofarma
INNOVATION
Going Beyond with
Constant New
Initiatives
Rooms
EUROLAB dedicated to the
development of
formulation and
analytical
Innovation Hub
methodologies
Other Initiatives
Synapsis
Eurofarma.
EMERGE
Program to
support
entrepreneurs with
high growth potential
Average growth of
59% in topline of
participant
companies
80% of
participants made
a pilot project with
Eurofarma
Project focused on further developing innovation by funding
scientists to take their academic research to market
Access to knowledge in biotech through limited partnership since 2020 with venture
capital fund (Abingworth)
+670 molecules
already
designed and
obtained for the
design of new drugs
Largest organic
synthesis laboratory
in LatAm dedicated to
small organic
molecules
ASView entire presentation